This inventor holds 1 USPTO granted patent. Top assignee: A. Nattermann & Cie Gmbh. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: **Ekkehard Harhausen: Innovator in Pharmaceutical Stability**
Introduction
Ekkehard Harhausen, based in Cologne, Germany, is a notable inventor with a contribution to the field of pharmaceuticals. He has been credited with a patent that aims to enhance the stability of pharmaceutical preparations, showcasing his commitment to innovation in medical science.
Latest Patents
Ekkehard Harhausen holds one patent for a stable pharmaceutical preparation comprising amitriptylin oxide dihydrate as an active substance, combined with an organic acid selected from hydroxy carboxylic acids, ketocarboxylic acids, or amino acids as a stabilizer. This invention includes conventional pharmaceutical auxiliaries and carrier substances, emphasizing the significance of stability in pharmaceutical formulations.
Career Highlights
Harhausen works at A. Nattermann & Cie GmbH, where his expertise in pharmaceuticals is applied to create significant advancements in drug formulations. His singular focus on stability in pharmaceutical preparations contributes to the quality and efficacy of medications available to patients.
Collaborations
Throughout his career, Ekkehard Harhausen has collaborated with talented professionals such as Manfred Durr and Benedikt Gajdos. These partnerships help foster innovation and drive research forward within their organization, producing notable advancements in the pharmaceutical industry.
Conclusion
Ekkehard Harhausen's contributions to the pharmaceutical sector highlight the critical role of inventors in advancing medical science. His work on the stability of pharmaceutical preparations is an essential part of drug development, ensuring safer and more effective treatments for patients worldwide. His legacy continues through ongoing research and collaboration in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile